Filing Details
- Accession Number:
- 0001181431-12-043554
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-03 17:27:52
- Reporting Period:
- 2012-08-01
- Filing Date:
- 2012-08-03
- Accepted Time:
- 2012-08-03 17:27:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001233 | Sangamo Biosciences Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234387 | William John Larson | C/O Sangamo Biosciences Inc. Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-08-01 | 700 | $5.20 | 282,460 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 2,400 | $5.21 | 280,060 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 1,500 | $5.22 | 278,560 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 800 | $5.23 | 277,760 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 100 | $5.24 | 277,660 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 100 | $5.26 | 277,560 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 1,500 | $5.27 | 276,060 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-01 | 7,900 | $5.28 | 268,160 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2012.